13.5
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
View the full transcript and gain access to JoVE Core videos
Q1: How does aging affect plasma protein concentration and drug binding?
Aging decreases albumin levels by approximately 10% while increasing α1-acid glycoprotein levels. These changes alter how drugs bind to plasma proteins, affecting drug distribution. Highly protein-bound drugs like warfarin require dosing adjustments to prevent toxicity in older patients.
Q2: Why do hydrophilic drugs like digoxin require dose adjustments in elderly patients?
Aging reduces lean body mass and total body water, decreasing the distribution volume for hydrophilic drugs such as digoxin, theophylline, and aminoglycosides. Lower distribution volumes result in higher plasma concentrations for equivalent doses, necessitating reduced dosing in older patients to maintain therapeutic safety.
Q3: What happens to lipophilic drug distribution as patients age?
Body fat increases with age, potentially raising the volume of distribution for lipophilic drugs like benzodiazepines. This increased distribution volume results in lower plasma drug concentrations for equivalent doses, requiring dose adjustments to achieve therapeutic drug concentrations in older patients.
Q4: Which drugs with narrow therapeutic indices require dosing adjustments in geriatric patients?
Drugs with narrow therapeutic indices and high extraction ratios, such as intravenously administered lidocaine and warfarin, require dosing regimen adjustments in older adults. These adjustments reduce toxicity risks caused by age-related changes in plasma protein concentration and body composition.
Q5: How do pathophysiological changes in aging affect drug distribution decisions?
Age-related alterations in albumin and α1-acid glycoprotein levels result from pathophysiological changes or diseases common in older individuals rather than aging alone. These changes may not always require dosing adjustments except for drugs with high extraction ratios and narrow therapeutic indices, making individual assessment essential.
Q6: What dosing strategy helps optimize pharmacotherapy in elderly patients?
Weight-based loading regimens tailored to individual body composition changes help optimize drug dosing in older patients. Generally, lower doses are recommended for elderly compared to younger patients, with adjustments to single or loading doses considering changes in lean body mass, total body water, and body fat.
Q7: Why is measuring tissue binding in elderly patients challenging?
The process of drug binding to tissues and how aging affects this binding remains poorly understood, primarily due to difficulties measuring tissue binding in vitro without compromising tissue integrity. This knowledge gap makes it harder to predict drug distribution changes in older patients and tailor dosing regimens precisely.